诊断学理论与实践 ›› 2023, Vol. 22 ›› Issue (02): 197-202.doi: 10.16150/j.1671-2870.2023.02.015
收稿日期:
2023-01-28
出版日期:
2023-04-25
发布日期:
2023-08-31
通讯作者:
李京波 E-mail:lijb@sjtu.edu.cn
基金资助:
Received:
2023-01-28
Online:
2023-04-25
Published:
2023-08-31
摘要:
心肌梗死诊治进展使部分患者的预后获得明显改善,但患者的总体生存率仍不理想。深入研究心肌缺血再灌注后损伤机制可能改善研究的方向。铁死亡作为近年来新发现的调节性细胞死亡方式,其是主要由脂质过氧化引起的铁依赖性细胞死亡,特点是细胞死亡涉及脂质过氧化物和活性氧的积累。铁死亡被认为在缺血再灌注损伤中发挥重要作用。研究提示心肌梗死后的铁死亡相关标志物出现变化包括,细胞内铁代谢中的线粒体铁蛋白(mitochondrial ferritin, FtMt)缺失,谷胱甘肽代谢途径的末端分子谷胱甘肽过氧化物酶4(glutathione peroxidase 4 ,Gpx4)水平下降、谷胱甘肽合成中氨基酸逆向转运蛋白胱氨酸/谷氨酸转运体系统(cystine/glutamate transporter, System xc-, SXc-)功能下降和脂质代谢酶酰基辅酶A合成酶长链家族成员4 (acyl-CoA synthetase long-chain family member 4, ACSL4)的过度表达,导致了心肌梗死后的氧化应激、炎症反应,加重心肌缺血再灌注损伤。FtMt、Gpx4、SXc-和ACSL4这4种生物标志物是心肌梗死后铁死亡相关诊治的重要研究靶点,值得深入研究。
中图分类号:
常宇宸, 李京波. 心肌梗死中铁死亡标志物研究进展[J]. 诊断学理论与实践, 2023, 22(02): 197-202.
CHANG Yuchen, LI Jingbo. Advances in biological markers of ferroptosis in myocardial infarction[J]. Journal of Diagnostics Concepts & Practice, 2023, 22(02): 197-202.
表1
铁死亡、细胞凋亡、细胞自噬和细胞焦亡的特征[9]
项目 | 形态学特征 | 生化特征 |
---|---|---|
铁死亡 | 线粒体小而畸形,线粒体嵴减少或消失,细胞膜浓缩,线粒体外膜破裂,细胞核正常 | 铁代谢异常,脂质过氧化,ROS积累 |
细胞坏死 | 质膜破裂、固缩、核裂、核溶解、染色质解体、核轮廓消失和细胞成分溢出 | ATP水平降低,DNA随机降解和扩散 |
细胞凋亡 | 细胞体积减少,细胞间连接消失,细胞骨架解体,染色质凝集,凋亡小体的形成 | Caspase蛋白激活,DNA片段,生物大分子合成 |
细胞自噬 | 完整的细胞膜,细胞质中的囊泡样结构和自噬小体的形成 | LC3-Ⅱ,P62、Beclin-1蛋白调控 |
细胞焦亡 | 细胞肿胀和增大,伴有气泡状突起,细胞膜破裂,内容物流出 | 炎症小体形成,Gasdermin D蛋白激活,促炎细胞因子释放 |
[1] | 王增武. 《基层冠心病与缺血性脑卒中共患管理专家共识2022》解读[J]. 中国心血管杂志, 2022, 27(5):411-416. |
WANG Z W. Interpretation of 2022 Expert Consensus on the Management of Coronary Heart Disease with Ische-mic Stroke in Community[J]. Chin J Cardiovasc Med, 2022, 27(5):411-416. | |
[2] | 中国心血管健康与疾病报告编写组. 中国心血管健康与疾病报告2021概要[J]. 心脑血管病防治, 2022, 22(4):20-36,40. |
The Writing Committee of the Report on Cardiovascular Health and Diseases in China. Special Report Report on cardiovascular health and diseases in China 2021: an updated summary[J]. Prev Treat Cardio-Cereb-Vascular Dis, 2022, 22(4):20-36,40. | |
[3] |
WU W, CHANG S, WU Q, et al. Mitochondrial ferritin protects the murine myocardium from acute exhaustive exercise injury[J]. Cell Death Dis, 2016, 7(11):e2475.
doi: 10.1038/cddis.2016.372 |
[4] | WANG L, WANG L, DAI Z, et al. Lack of mitochondrial ferritin aggravated neurological deficits via enhancing oxidative stress in a traumatic brain injury murine model[J]. Biosci Rep, 2017, 37(6):BSR20170942. |
[5] |
DOLMA S, LESSNICK S L, HAHN W C, et al. Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells[J]. Cancer Cell, 2003, 3(3):285-296.
doi: 10.1016/s1535-6108(03)00050-3 pmid: 12676586 |
[6] |
DIXON S J, LEMBERG K M, LAMPRECHT M R, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death[J]. Cell, 2012, 149(5):1060-1072.
doi: 10.1016/j.cell.2012.03.042 pmid: 22632970 |
[7] |
YANG W S, STOCKWELL B R. Synthetic lethal scree-ning identifies compounds activating iron-dependent, non-apoptotic cell death in oncogenic-RAS-harboring cancer cells[J]. Chem Biol, 2008, 15(3):234-245.
doi: 10.1016/j.chembiol.2008.02.010 URL |
[8] |
LI X, LIANG J, QU L, et al. Exploring the role of ferroptosis in the doxorubicin-induced chronic cardiotoxicity using a murine model[J]. Chem Biol Interact, 2022, 363:110008.
doi: 10.1016/j.cbi.2022.110008 URL |
[9] |
LV J, HOU B, SONG J, et al. The Relationship Between Ferroptosis and Diseases[J]. J Multidiscip Healthc, 2022, 15:2261-2275.
doi: 10.2147/JMDH.S382643 pmid: 36225859 |
[10] | ZHENG Y, QIN C, LI F, et al. Self-assembled thioether-bridged paclitaxel-dihydroartemisinin prodrug for amplified antitumor efficacy-based cancer ferroptotic-chemotherapy[J]. Biomater Sci. 2023 May 2;11(9):3321-3334. |
[11] |
MAGTANONG L, KO P J, DIXON S J. Emerging roles for lipids in non-apoptotic cell death[J]. Cell Death Differ, 2016, 23(7):1099-1109.
doi: 10.1038/cdd.2016.25 pmid: 26967968 |
[12] | LILLO-MOYA J, ROJAS-SOLÉ C, MUÑOZ-SALAMANCA D, et al. Targeting Ferroptosis against Ischemia/Reperfusion Cardiac Injury[J]. Antioxidants (Basel), 2021, 10(5):667. |
[13] |
MACCARINELLI F, GAMMELLA E, ASPERTI M, et al. Mice lacking mitochondrial ferritin are more sensitive to doxorubicin-mediated cardiotoxicity[J]. J Mol Med (Berl), 2014, 92(8):859-869.
doi: 10.1007/s00109-014-1147-0 pmid: 24728422 |
[14] |
GANZ T. Systemic iron homeostasis[J]. Physiol Rev, 2013, 93(4):1721-1741.
doi: 10.1152/physrev.00008.2013 pmid: 24137020 |
[15] |
GOZZELINO R, SOARES M P. Coupling heme and iron metabolism via ferritin H chain[J]. Antioxid Redox Signal, 2014, 20(11):1754-1769.
doi: 10.1089/ars.2013.5666 URL |
[16] |
PHAM C G, BUBICI C, ZAZZERONI F, et al. Ferritin heavy chain upregulation by NF-kappaB inhibits TNFalpha-induced apoptosis by suppressing reactive oxygen species[J]. Cell, 2004, 119(4):529-542.
doi: 10.1016/j.cell.2004.10.017 pmid: 15537542 |
[17] |
CHEN X, YU C, KANG R, et al. Iron Metabolism in Ferroptosis[J]. Front Cell Dev Biol, 2020, 8:590226.
doi: 10.3389/fcell.2020.590226 URL |
[18] |
WANG P, CUI Y, REN Q, et al. Mitochondrial ferritin attenuates cerebral ischaemia/reperfusion injury by inhibiting ferroptosis[J]. Cell Death Dis, 2021, 12(5):447.
doi: 10.1038/s41419-021-03725-5 pmid: 33953171 |
[19] |
WANG P, CUI Y, REN Q, et al. Mitochondrial ferritin attenuates cerebral ischaemia/reperfusion injury by inhibi-ting ferroptosis[J]. Cell Death Dis, 2021, 12(5):447.
doi: 10.1038/s41419-021-03725-5 |
[20] |
WU W, CHANG S, WU Q, et al. Mitochondrial ferritin protects the murine myocardium from acute exhaustive exercise injury[J]. Cell Death Dis, 2016, 7(11):e2475.
doi: 10.1038/cddis.2016.372 |
[21] |
MACCARINELLI F, GAMMELLA E, ASPERTI M, et al. Mice lacking mitochondrial ferritin are more sensitive to doxorubicin-mediated cardiotoxicity[J]. J Mol Med (Berl), 2014, 92(8):859-869.
doi: 10.1007/s00109-014-1147-0 pmid: 24728422 |
[22] |
FUHRMANN D C, MONDORF A, BEIFUß J, et al. Hypoxia inhibits ferritinophagy, increases mitochondrial ferritin, and protects from ferroptosis[J]. Redox Biol, 2020, 36:101670.
doi: 10.1016/j.redox.2020.101670 URL |
[23] |
CAMPANELLA A, ROVELLI E, SANTAMBROGIO P, et al. Mitochondrial ferritin limits oxidative damage regulating mitochondrial iron availability: hypothesis for a protective role in Friedreich ataxia[J]. Hum Mol Genet, 2009, 18(1):1-11.
doi: 10.1093/hmg/ddn308 pmid: 18815198 |
[24] |
XIE K, MO Y, YUE E, et al. Exosomes derived from M2-type microglia ameliorate oxygen-glucose deprivation/reoxygenation-induced HT22 cell injury by regulating miR-124-3p/NCOA4-mediated ferroptosis[J]. Heliyon, 2023, 9(7):e17592.
doi: 10.1016/j.heliyon.2023.e17592 URL |
[25] | XU W, SUN T, WANG J, et al. GPX4 Alleviates Diabetes Mellitus-Induced Erectile Dysfunction by Inhibiting Ferroptosis[J]. Antioxidants (Basel), 2022, 11(10):1896. |
[26] |
INGOLD I, BERNDT C, SCHMITT S, et al. Selenium Utilization by GPX4 Is Required to Prevent Hydroperoxide-Induced Ferroptosis[J]. Cell, 2018, 172(3):409-422.
doi: S0092-8674(17)31438-1 pmid: 29290465 |
[27] |
HOLMSTRÖM K M, FINKEL T. Cellular mechanisms and physiological consequences of redox-dependent signalling[J]. Nat Rev Mol Cell Biol, 2014, 15(6):411-421.
doi: 10.1038/nrm3801 |
[28] |
XUE Q, YAN D, CHEN X, et al. Copper-dependent autophagic degradation of GPX4 drives ferroptosis[J]. Autophagy, 2023, 19(7):1982-1996.
doi: 10.1080/15548627.2023.2165323 URL |
[29] |
SHIMADA K, SKOUTA R, KAPLAN A, et al. Global survey of cell death mechanisms reveals metabolic regulation of ferroptosis[J]. Nat Chem Biol, 2016, 12(7):497-503.
doi: 10.1038/nchembio.2079 pmid: 27159577 |
[30] |
YANG L, CHEN X, YANG Q, et al. Broad Spectrum Deubiquitinase Inhibition Induces Both Apoptosis and Ferroptosis in Cancer Cells[J]. Front Oncol, 2020, 10:949.
doi: 10.3389/fonc.2020.00949 pmid: 32596160 |
[31] |
LIU Y, WANG Y, LIU J, et al. Interplay between MTOR and GPX4 signaling modulates autophagy-dependent ferroptotic cancer cell death[J]. Cancer Gene Ther, 2021, 28(1-2):55-63.
doi: 10.1038/s41417-020-0182-y |
[32] |
JIANG Y, QIAO Y, HE D, et al. Adaptor protein HIP-55-mediated signalosome protects against ferroptosis in myocardial infarction[J]. Cell Death Differ, 2023, 30(3):825-838.
doi: 10.1038/s41418-022-01110-z pmid: 36639542 |
[33] |
BRIDGES R J, NATALE N R, PATEL S A. System xc⁻ cystine/glutamate antiporter: an update on molecular pharmacology and roles within the CNS[J]. Br J Pharmacol, 2012, 165(1):20-34.
doi: 10.1111/j.1476-5381.2011.01480.x URL |
[34] |
LI Y, YAN J, ZHAO Q, et al. ATF3 promotes ferroptosis in sorafenib-induced cardiotoxicity by suppressing Slc7a11 expression[J]. Front Pharmacol, 2022, 13:904314.
doi: 10.3389/fphar.2022.904314 URL |
[35] | HUANG Y B, JIANG L, LIU X Q, et al. Melatonin Allevia-tes Acute Kidney Injury by Inhibiting NRF2/Slc7a11 Axis-Mediated Ferroptosis[J]. Oxid Med Cell Longev, 2022, 2022:4776243. |
[36] |
LIU T, SHU J, LIU Y, et al. Liu T, Shu J, Li L, et al. Atorvastatin attenuates ferroptosis-dependent myocardial injury and inflammation following coronary microembolization via the Hif1a/Ptgs2 pathway[J]. Front Pharmacol, 2022, 13:1057583.
doi: 10.3389/fphar.2022.1057583 URL |
[37] |
LI Y, FENG D, WANG Z, et al. Ischemia-induced ACSL4 activation contributes to ferroptosis-mediated tissue injury in intestinal ischemia/reperfusion[J]. Cell Death Differ, 2019, 26(11):2284-2299.
doi: 10.1038/s41418-019-0299-4 pmid: 30737476 |
[38] |
DOLL S, PRONETH B, TYURINA Y Y, et al. ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition[J]. Nat Chem Biol, 2017, 13(1):91-98.
doi: 10.1038/nchembio.2239 pmid: 27842070 |
[39] |
SUN L, WANG H, XU D, et al. Lapatinib induces mitochondrial dysfunction to enhance oxidative stress and ferroptosis in doxorubicin-induced cardiomyocytes via inhibition of PI3K/AKT signaling pathway[J]. Bioengineered, 2022, 13(1):48-60.
doi: 10.1080/21655979.2021.2004980 pmid: 34898356 |
[1] | 陈国群, 蔡姣迪. 2022年美国国立综合癌症网络(NCCN)《非小细胞肺癌临床诊疗指南》(第4版及第5版)解读[J]. 诊断学理论与实践, 2023, 22(01): 8-13. |
[2] | 李佳曦, 汪锦江, 俞立萍, 袁英, 乔光磊, 马俐君. RAB25沉默抑制结直肠癌细胞铁死亡的作用研究[J]. 诊断学理论与实践, 2022, 21(06): 710-718. |
[3] | 武冬冬, 陈玉辉, 刘芳, 刘银红, 蒋景文. 脑小血管疾病合并中枢神经系统退行性疾病机制的研究进展[J]. 诊断学理论与实践, 2022, 21(05): 644-649. |
[4] | 周思锋, 徐海舒, 范欣生. 基于不同生物样本代谢组学的OSAHS生物标志物研究进展[J]. 诊断学理论与实践, 2022, 21(04): 535-540. |
[5] | 王春花, 祁爽, 王敏. 原发性醛固酮增多症合并无痛性心肌梗死一例报告[J]. 诊断学理论与实践, 2020, 19(05): 528-530. |
[6] | 罗晓颖, 许燕, 张建盛, 吴立群, 戚文航. N端脑钠肽前体预测首次急性心肌梗死后新发心房颤动的价值研究[J]. 诊断学理论与实践, 2020, 19(03): 303-307. |
[7] | 陈海燕, 杨小宝, 许大康. 新生物标志物在胃肠道肿瘤中疗效预测和预后价值的研究进展[J]. 诊断学理论与实践, 2019, 18(06): 704-710. |
[8] | 罗清琼, 陈福祥. 肿瘤免疫治疗策略的转变及相关标志物研究现状[J]. 诊断学理论与实践, 2019, 18(04): 387-393. |
[9] | 杜坤, 杨喜, 卞炳贤, 任懿倩, 张广慧. 血清presepsin(sCD14-ST)、降钙素原、C反应蛋白和白介细胞素-6诊断血流细菌感染的诊断性能比较[J]. 诊断学理论与实践, 2018, 17(05): 581-585. |
[10] | 崔诗爽, 陈生弟, 王刚. 帕金森病体液生物标志物研究进展[J]. 诊断学理论与实践, 2018, 17(04): 471-476. |
[11] | 陈媛媛, 王燕萍, 吴丽苹, 陈亚芬, 杨克, 刘艳. 卵泡抑素样蛋白1及其在心血管疾病中的作用研究进展[J]. 诊断学理论与实践, 2017, 16(06): 659-663. |
[12] | 牟姗, 陈哲君, 谢园园. 生物标志物在肾脏损伤诊断中的临床应用[J]. 诊断学理论与实践, 2017, 16(04): 358-362. |
[13] | 周桑, 沈茜, 秦永文. 肌钙蛋白I自身抗体在心肌梗死诊断中的临床意义[J]. 诊断学理论与实践, 2017, 16(01): 120-122. |
[14] | 万颖蕾, 倪逸敏, 顾志冬. 心型脂肪酸结合蛋白在急性心肌梗死患者早期诊断中的应用价值[J]. 诊断学理论与实践, 2016, 15(06): 582-585. |
[15] | 张月琪, 任汝静, 王刚,. 尿液生物标志物对痴呆诊断价值的研究进展[J]. 诊断学理论与实践, 2016, 15(02): 190-194. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||